BioNTech Strengthens Its Artificial Intelligence With Acquisition Of British Startup

  • BioNTech SE BNTX has agreed to acquire InstaDeep Ltd, a technology company in the field of artificial intelligence ("AI") and machine learning.
  • The transaction includes an upfront consideration of approximately £362 million in cash and BioNTech shares.
  • In addition, InstaDeep shareholders will be eligible to receive additional performance-based future milestone payments of up to approximately £200 million. 
  • Related: BioNTech Stock Gets Upgrade, Analyst Sees Multiple Upside Opportunities.
  • The transaction follows BioNTech's initial equity investment as part of InstaDeep's Series B financing round in January 2022.
  • The acquisition supports BioNTech's strategy to build capabilities in AI-driven drug discovery and develop next-generation immunotherapies and vaccines.
  • The transaction will combine two organizations with a common culture and add approximately 240 highly skilled professionals to BioNTech's workforce.
  • The transaction is expected to close in the first half of 2023.
  • Price Action: BNTX shares are up 3.06% at $153.32 on the last check Tuesday.
Market News and Data brought to you by Benzinga APIs
Posted In: BiotechM&ANewsHealth CareMoversTechTrading IdeasGeneralBriefs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!